Investigation of characteristics and prescription status and occurrence of cardiovascular and renal disease events in patients with hyperuricemia or gout

Investigation of characteristics and prescription status and occurrence of cardiovascular and renal disease events in patients with hyperuricemia or gout - Investigation of various conditions in patients with hyperuricemia or gout

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045426

Enrollment

60000

Registered

2021-09-10

Start date

2020-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperuricemia or gout

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Database registrations within the total data period. 2. Continuing contract with the health insurance association in which they participated at the end of the total data period. 3. The first (oldest) diagnosis of hyperuricemia or gout (referred to as the index diagnosis) was within the inclusion period. 4. Twelve months of observations were available retrospectively from the time of the index diagnosis. 5. No record of ULD prescription prior to the index diagnosis. 6. Age over 20 years at the index diagnosis.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Patient characteristics and treatment status	—

Countries

Japan

Contacts

Public ContactSeigo Akari

Sanwa Kagaku Kenkyusho Co.,Ltd. Medical Affairs Department

s_akari@skk-net.com052-951-8130

Outcome results